Tracing the European course of cardiac resynchronization therapy from 2006 to 2008

Europace

Volumn 12, Issue 5, 2010, Pages 692-701

  Merkely, Bela ^a   Roka, Attila ^a   Kutyifa, Valentina ^a   Boersma, Lucas ^b   Leenhardt, Antoine ^c   Lubinski, Andrzej ^d   Oto, Ali ^e   Proclemer, Alessandro ^f   Brugada, Josep ^g   Vardas, Panos E ^h   Wolpert, Christian ⁱ  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c HÔPITAL LARIBOISIÈRE   (France)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e HACETTEPE UNIVERSITY   (Turkey)

^f SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

ⁱ KLINIKUM LUDWIGSBURG   (Germany)

Author keywords

Cardiac resynchronization therapy; Europe; Implantable cardioverter defibrillator; Pacemaker; Reimbursement

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; EUROPE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HEALTH SURVEY; HEART ARRHYTHMIA; HUMAN; IMPLANTATION; MEDICAL SOCIETY; PRIORITY JOURNAL; REIMBURSEMENT; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; ECONOMICS; HEALTH CARE POLICY; HEART FAILURE; HEART PACING; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION;

ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; DATA COLLECTION; DEFIBRILLATORS, IMPLANTABLE; EUROPE; HEALTH POLICY; HEART FAILURE; HUMANS; INSURANCE, HEALTH; INTERNATIONAL COOPERATION; PACEMAKER, ARTIFICIAL; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 77951959670     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq041     Document Type: Article

References (28)

1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-72.
2. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-402. (Pubitemid 35239711)
3. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50.
4. Russell SD, Miller LW, Pagani FD. Advanced heart failure: a call to action. Congest Heart Fail 2008;14:316-21.
5. Kass DA. An epidemic of dyssynchrony: but what does it mean? J Am Coll Cardiol 2008;51:12-7.
6. Cazeau S, Ritter P, Bakdach S, Lazarus A, Limousin M, Henao L et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974-9.
7. Bakker PF, Meijburg HW, de Vries JW, Mower MM, Thomas AC, Hull ML et al. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Interv Card Electrophysiol 2000;4:395-404.
8. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) : the Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.
9. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
10. Vardas PE, Auricchio A, Blanc J, Daubert J, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95.
11. Epstein AE, DiMarco JP, Ellenbogen KA, Freedman RA, Gettes LS, Gillinov AM et al., Estes NAM3. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51: e1-62.
12. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-60.
13. van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11:1143-51.
14. The EHRA White Book. July 2008. http://www.escardio.org/communities/EHRA/ publications/Documents/ehra-white-book-2008.pdf.
15. The EHRA White Book. July 2009. http://www.escardio.org/communities/EHRA/ publications/Documents/ehra-white-book-2009.pdf.
16. Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008;118:926-33.
17. CRT Survey Scientific Committee. European cardiac resynchronization therapy survey: rationale and design. Eur J Heart Fail 2009;11:326-30.
18. Calvert MJ, Freemantle N, Yao G, Cleland JGF, Billingham L, Daubert J et al. Costeffectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J 2005;26:2681-8.
19. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert J, Cleland JGF. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007;28:42-51.
20. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al., Estes NAM3. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
21. Cleland JGF, Freemantle N, Daubert J, Toff WD, Leisch F, Tavazzi L. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart 2008;94:278-83.
22. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. Dualchamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002;288:3115-23.
23. Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP et al. Long-term clinical response of cardiac resynchronization after chronic right ventricular pacing. Am J Cardiol 2009;104:116-21.
24. Funck RC, Blanc J, Mueller H, Schade-Brittinger C, Bailleul C, Maisch B. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'biventricular pacing for atrioventricular block to prevent cardiac desynchronization (BioPace) ' study. Europace 2006;8:629-35.
25. Szilagyi S, Merkely B, Roka A, Zima E, Fulop G, Kutyifa V et al. Stabilization of the coronary sinus electrode position with coronary stent implantation to prevent and treat dislocation. J Cardiovasc Electrophysiol 2007;18:303-7.
26. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
27. Cleland JGF, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
28. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43.